Galenica to acquire U.S. biopharma firm Relypsa for $1.53 billion in cash

July 21, 2016 5:48 AM

21 0

Galenica (GALN.S) said it has agreed to buy U.S. biopharma company Relypsa (RLYP.O) for $1.53 billion in cash to strengthen its Vifor Pharma unit.

Galenica's $32 per share offer for Relypsa shares represents a 59 percent premium to Wednesday's close.

Also read: China to boost non-fossil fuel use to 20 percent by 2030: state planner

Read more

To category page